Risk Factors for Colorectal Cancer Following Breast Cancer Leanne M. KmetLinda S. CookEmily White OriginalPaper Pages: 143 - 147
Higher Stromal Expression of Transforming Growth Factor-beta Type II Receptors is Associated with Poorer Prognosis Breast Tumors John BarlowDavid YandellKaren Plaut OriginalPaper Pages: 149 - 159
Effect of Exogenous Epidermal-Like Growth Factors on Mammary Gland Development and Differentiation in the Estrogen Receptor-Alpha Knockout (ERKO) Mouse Nicholas J. KenneyArthur BowmanDavid S. Salomon OriginalPaper Pages: 161 - 173
Expression of the CCAAT/Enhancer-Binding Proteins C/EBPα, C/EBPβ and C/EBPδ in Breast Cancer: Correlations with Clinicopathologic Parameters and Cell-Cycle Regulatory Proteins Karin Milde-LangoschThomas LöningAna-Maria Bamberger OriginalPaper Pages: 175 - 185
EGFR, HER-2/neu, Cyclin D1, p21 and p53 in Correlation to Cell Proliferation and Steroid Hormone Receptor Status in Ductal Carcinoma in situ of the Breast Annette LebeauAngela UnholzerUdo Löhrs OriginalPaper Pages: 187 - 198
Acceptability of Diagnostic Tests for Breast Cancer Wenchi LiangWilliam F. LawrenceMarc E. Lippman OriginalPaper Pages: 199 - 206
Postmenopausal Women who Progress on Fulvestrant ('Faslodex') Remain Sensitive to Further Endocrine Therapy I. VergoteJ.F.R. RobertsonL. Mauriac OriginalPaper Pages: 207 - 211
Hormone Replacement Therapy after Treatment for Breast Cancer: Physicians' Attitudes towards Randomized Trials ME Del GiudiceCA SawkaE Franssen OriginalPaper Pages: 213 - 223
Treatment of Early Stage Breast Cancer: do Surgeons and Patients Agree Regarding Whether Treatment Alternatives were Discussed? Nancy L. KeatingJane C. WeeksEdward Guadagnoli OriginalPaper Pages: 225 - 231
Effects of Long-Term HRT and Tamoxifen on the Expression of Progesterone Receptors A and B in Breast Tissue from Surgically Postmenopausal Cynomolgus Macaques E. IsakssonH. WangE. von Schoultz OriginalPaper Pages: 233 - 239
Prolactin Overexpression by MDA-MB-435 Human Breast Cancer Cells Accelerates Tumor Growth Karen LibyBonnie NeltnerNira Ben-Jonathan OriginalPaper Pages: 241 - 252
Phosphocitrate Inhibits Calcium Hydroxyapatite Induced Mitogenesis and Upregulation of Matrix Metalloproteinase-1, Interleukin-1β and Cyclooxygenase-2 mRNA in Human Breast Cancer Cell Lines Michelle M. CookeGeraldine M. McCarthyMaria P. Morgan OriginalPaper Pages: 253 - 263
Nutrition and Lifestyle Factors on the Risk of Developing Breast Cancer Bernd GerberHeiner MüllerKlaus Friese OriginalPaper Pages: 265 - 276
2. Survival Impact of HER-2/Neu, Cox-2, Urokinase Plasminogen Activator (upa), Cytokeratin 17/5,6 and other Markers with Long-Term Outcome of Early Breast Cancer. Report from the British Columbia Tissue Micro-Array Project (BCTMAP) J. RagazM. LippmanD. Hayes OriginalPaper Pages: 278 - 278
158. Pathological Complete Response is not the Best Prognostic Factor in Patients with Breast Cancer Treated by Preoperative Chemotherapy A. HonigE.F. SolomayerD. Wallweiner OriginalPaper Pages: 279 - 279
290. Phase I Study of Pemetrexed (ALIMTA) and Epirubicin in Patients with Locally Advanced or Metastatic Breast Cancer R. ParidaensL. DirixH. Dumez OriginalPaper Pages: 280 - 280
